• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞分析揭示胶质母细胞瘤中肿瘤相关巨噬细胞的多样性及其与 T 淋巴细胞的相互作用。

Single-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma.

机构信息

Cooper Medical School of Rowan University, Camden, NJ, 08103, USA.

Department of Neurology, Cooper University Health Care, Camden, NJ, USA.

出版信息

Sci Rep. 2023 Nov 27;13(1):20874. doi: 10.1038/s41598-023-48116-2.

DOI:10.1038/s41598-023-48116-2
PMID:38012322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10682178/
Abstract

Glioblastoma (GBM) is an aggressive primary CNS malignancy and clinical outcomes have remained stagnant despite introduction of new treatments. Understanding the tumor microenvironment (TME) in which tumor associated macrophages (TAMs) interact with T cells has been of great interest. Although previous studies examining TAMs in GBM have shown that certain TAMs are associated with specific clinical and/or pathologic features, these studies used an outdated M1/M2 paradigm of macrophage polarization and failed to include the continuum of TAM states in GBM. Perhaps most significantly, the interactions of TAMs with T cells have yet to be fully explored. Our study uses single-cell RNA sequencing data from adult IDH-wildtype GBM, with the primary aim of deciphering the cellular interactions of the 7 TAM subtypes with T cells in the GBM TME. Furthermore, the interactions discovered herein are compared to IDH-mutant astrocytoma, allowing for focus on the cellular ecosystem unique to GBM. The resulting ligand-receptor interactions, signaling sources, and global communication patterns discovered provide a framework for future studies to explore methods of leveraging the immune system for treating GBM.

摘要

胶质母细胞瘤(GBM)是一种侵袭性的中枢神经系统原发性恶性肿瘤,尽管引入了新的治疗方法,但临床结果仍停滞不前。了解肿瘤相关巨噬细胞(TAMs)与 T 细胞相互作用的肿瘤微环境(TME)一直是人们极大的兴趣所在。尽管先前研究 GBM 中的 TAMs 表明某些 TAMs 与特定的临床和/或病理特征相关,但这些研究使用了过时的巨噬细胞极化 M1/M2 范式,并且未能包括 GBM 中 TAM 状态的连续体。也许最重要的是,TAMs 与 T 细胞的相互作用尚未得到充分探索。我们的研究使用来自成人 IDH 野生型 GBM 的单细胞 RNA 测序数据,主要目的是破译 7 种 TAM 亚型与 GBM TME 中的 T 细胞的细胞相互作用。此外,本文中发现的相互作用与 IDH 突变星形细胞瘤进行了比较,从而可以专注于 GBM 特有的细胞生态系统。发现的配体-受体相互作用、信号源和全局通信模式为未来的研究提供了一个框架,以探索利用免疫系统治疗 GBM 的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/ac3fe2c6e4ea/41598_2023_48116_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/6c400e677f92/41598_2023_48116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/d0870936e54a/41598_2023_48116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/bf0861547255/41598_2023_48116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/97d1e9b9440c/41598_2023_48116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/80a1d8ab827a/41598_2023_48116_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/f5677cd50614/41598_2023_48116_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/280fe9bb5eae/41598_2023_48116_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/ac3fe2c6e4ea/41598_2023_48116_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/6c400e677f92/41598_2023_48116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/d0870936e54a/41598_2023_48116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/bf0861547255/41598_2023_48116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/97d1e9b9440c/41598_2023_48116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/80a1d8ab827a/41598_2023_48116_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/f5677cd50614/41598_2023_48116_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/280fe9bb5eae/41598_2023_48116_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0a2/10682178/ac3fe2c6e4ea/41598_2023_48116_Fig8_HTML.jpg

相似文献

1
Single-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma.单细胞分析揭示胶质母细胞瘤中肿瘤相关巨噬细胞的多样性及其与 T 淋巴细胞的相互作用。
Sci Rep. 2023 Nov 27;13(1):20874. doi: 10.1038/s41598-023-48116-2.
2
Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics.单细胞和空间转录组学揭示 IDH 分层胶质瘤微环境中的独特肿瘤-TAM 相互作用。
Acta Neuropathol Commun. 2024 Aug 16;12(1):133. doi: 10.1186/s40478-024-01837-5.
3
The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma.FKBP51s 剪接异构体预测胶质母细胞瘤患者预后不良。
Cancer Res Commun. 2024 May 16;4(5):1296-1306. doi: 10.1158/2767-9764.CRC-24-0083.
4
Distinct regional ontogeny and activation of tumor associated macrophages in human glioblastoma.人类脑胶质瘤中肿瘤相关巨噬细胞的独特区域发生和激活。
Sci Rep. 2020 Nov 11;10(1):19542. doi: 10.1038/s41598-020-76657-3.
5
The CEBPB glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote malignancy growth.CEBPB 胶质母细胞瘤亚群特异性地驱动 M2 肿瘤相关巨噬细胞的形成,从而促进恶性肿瘤生长。
Theranostics. 2024 Jul 2;14(10):4107-4126. doi: 10.7150/thno.93473. eCollection 2024.
6
The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.肿瘤相关巨噬细胞的异质性对胶质母细胞瘤患者的复发和预后有影响。
J Mol Neurosci. 2023 Jan;73(1):1-14. doi: 10.1007/s12031-022-02081-z. Epub 2022 Dec 21.
7
Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition.胶质母细胞瘤的遗传驱动因素决定了肿瘤相关巨噬细胞/小胶质细胞的功能以及对 CSF1R 抑制的反应。
Neuro Oncol. 2022 Apr 1;24(4):584-597. doi: 10.1093/neuonc/noab228.
8
EMP3 mediates glioblastoma-associated macrophage infiltration to drive T cell exclusion.EMP3 介导胶质母细胞瘤相关巨噬细胞浸润以驱动 T 细胞排斥。
J Exp Clin Cancer Res. 2021 May 8;40(1):160. doi: 10.1186/s13046-021-01954-2.
9
Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization.依托咪酯通过调控 M1 型巨噬细胞极化抑制脑胶质母细胞瘤生长。
Metab Brain Dis. 2024 Apr;39(4):569-576. doi: 10.1007/s11011-023-01335-y. Epub 2024 Feb 1.
10
Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies.脑胶质瘤中肿瘤相关巨噬细胞与肿瘤细胞的相互作用:探索有前景的靶向治疗方法。
Expert Rev Neurother. 2018 Sep;18(9):729-737. doi: 10.1080/14737175.2018.1510321. Epub 2018 Aug 22.

引用本文的文献

1
Glioblastoma: From Pathophysiology to Novel Therapeutic Approaches.胶质母细胞瘤:从病理生理学到新型治疗方法
Biomedicines. 2025 Aug 12;13(8):1963. doi: 10.3390/biomedicines13081963.
2
Trigeminal nerve-driven neurogenic inflammation linking migraine to glioblastoma invasion: a literature review.三叉神经驱动的神经源性炎症将偏头痛与胶质母细胞瘤侵袭联系起来:文献综述
Front Immunol. 2025 Jul 16;16:1632154. doi: 10.3389/fimmu.2025.1632154. eCollection 2025.
3
Rational therapeutic targeting of myeloid cells in glioblastoma: challenges and perspectives.

本文引用的文献

1
Overexpression of CD99 is associated with tumor adaptiveness and indicates the tumor recurrence and therapeutic responses in gliomas.CD99的过表达与肿瘤适应性相关,并提示胶质瘤的肿瘤复发及治疗反应。
Transl Oncol. 2023 Nov;37:101759. doi: 10.1016/j.tranon.2023.101759. Epub 2023 Aug 12.
2
CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis.CD44 是一个潜在的免疫治疗靶点,它影响巨噬细胞浸润,导致预后不良。
Sci Rep. 2023 Jun 14;13(1):9657. doi: 10.1038/s41598-023-33915-4.
3
Deficiency of angiopoietin-like 4 enhances CD8 T cell bioactivity via metabolic reprogramming for impairing tumour progression.
胶质母细胞瘤中髓样细胞的合理治疗靶点:挑战与展望
Front Immunol. 2025 Jun 26;16:1472710. doi: 10.3389/fimmu.2025.1472710. eCollection 2025.
4
Orchestration of Tumor-Associated Macrophages in the Tumor Cell-Macrophage-CD8 T Cell Loop for Cancer Immunotherapy.肿瘤细胞-巨噬细胞-CD8 T细胞循环中肿瘤相关巨噬细胞的调控用于癌症免疫治疗
Int J Biol Sci. 2025 Jun 12;21(9):4098-4116. doi: 10.7150/ijbs.115932. eCollection 2025.
5
Chemosensor receptors are lipid-detecting regulators of macrophage function in cancer.化学传感器受体是癌症中巨噬细胞功能的脂质检测调节因子。
Nat Immunol. 2025 Jul;26(7):1182-1197. doi: 10.1038/s41590-025-02191-x. Epub 2025 Jun 30.
6
Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy.探索胶质母细胞瘤中肿瘤相关巨噬细胞:从多样性到治疗
NPJ Precis Oncol. 2025 May 2;9(1):126. doi: 10.1038/s41698-025-00920-x.
7
The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses.C/EBPβ拮抗剂肽lucicebtide(ST101)可诱导巨噬细胞向促炎表型极化,并增强抗肿瘤免疫反应。
Front Immunol. 2025 Mar 4;16:1522699. doi: 10.3389/fimmu.2025.1522699. eCollection 2025.
8
Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma.肿瘤浸润性和循环性B细胞介导胶质母细胞瘤的局部和全身免疫调节机制。
J Neurooncol. 2025 May;172(3):527-548. doi: 10.1007/s11060-025-04989-z. Epub 2025 Mar 13.
9
A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression.一种用于研究坏死作为神经胶质瘤重塑和进展驱动力的临床相关模型和方法。
Proc Natl Acad Sci U S A. 2025 Feb 18;122(7):e2416024122. doi: 10.1073/pnas.2416024122. Epub 2025 Feb 13.
10
Divergent Crosstalk Between Microglia and T Cells in Brain Cancers: Implications for Novel Therapeutic Strategies.脑癌中微胶质细胞与T细胞之间的不同串扰:对新型治疗策略的启示
Biomedicines. 2025 Jan 16;13(1):216. doi: 10.3390/biomedicines13010216.
血管生成素样蛋白 4 的缺乏通过代谢重编程增强 CD8 T 细胞的生物活性,从而损害肿瘤进展。
Immunology. 2023 Sep;170(1):28-46. doi: 10.1111/imm.13650. Epub 2023 Apr 24.
4
T cell exhaustion in malignant gliomas.恶性脑胶质瘤中的 T 细胞耗竭。
Trends Cancer. 2023 Apr;9(4):270-292. doi: 10.1016/j.trecan.2022.12.008. Epub 2023 Jan 19.
5
Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cells.肿瘤细胞无法将癌基因衍生的 MHC-II 限制性表位呈递给 CD4+ T 细胞。
JCI Insight. 2023 Jan 24;8(2):e165570. doi: 10.1172/jci.insight.165570.
6
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells.PRDM1/BLIMP1 通过调节肝癌细胞中的 USP22-SPI1-PD-L1 轴诱导癌症免疫逃逸。
Nat Commun. 2022 Dec 12;13(1):7677. doi: 10.1038/s41467-022-35469-x.
7
Immune checkpoint gene VSIR predicts patient prognosis in acute myeloid leukemia and myelodysplastic syndromes.免疫检查点基因 VSIR 可预测急性髓系白血病和骨髓增生异常综合征患者的预后。
Cancer Med. 2023 Mar;12(5):5590-5602. doi: 10.1002/cam4.5409. Epub 2022 Nov 16.
8
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma.空间分辨多组学解析胶质母细胞瘤中肿瘤-宿主的双向相互依赖关系。
Cancer Cell. 2022 Jun 13;40(6):639-655.e13. doi: 10.1016/j.ccell.2022.05.009.
9
Macrophage diversity in cancer revisited in the era of single-cell omics.单细胞组学时代重新审视癌症中的巨噬细胞多样性。
Trends Immunol. 2022 Jul;43(7):546-563. doi: 10.1016/j.it.2022.04.008. Epub 2022 Jun 9.
10
Immune Checkpoint Inhibitors in Cancer Therapy.癌症治疗中的免疫检查点抑制剂。
Curr Oncol. 2022 Apr 24;29(5):3044-3060. doi: 10.3390/curroncol29050247.